Reproductive Biology, Journal Year: 2024, Volume and Issue: 25(1), P. 100968 - 100968
Published: Dec. 16, 2024
Language: Английский
European Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: 206, P. 107005 - 107005
Published: Jan. 11, 2025
Language: Английский
Citations
1
Asian Journal of Agricultural and Horticultural Research, Journal Year: 2024, Volume and Issue: 11(3), P. 37 - 49
Published: July 15, 2024
Agricultural waste represents a largely untapped resource that could be utilized for the production of biofuels through various conversion pathways. As global demand renewable and sustainable energy grows, offer solutions to mitigate climate change impacts while improving management. This review analyzes using agricultural residues by-products as feedstocks biofuel biological, thermochemical chemical processes. The different types lignocellulosic biomass available from activities are discussed, along with their compositions. While has advantages like wide availability low cost, challenges relating heterogeneous composition, pre-existing contamination seasonal must addressed. Fermentation, anaerobic digestion, pyrolysis gasification examined established routes converting into liquid biogas. Pretreatment methods, enzyme pathways synthesis fuels ethanol, butanol diesel substitutes outlined. Environmental benefits waste, including greenhouse gas mitigation recycling soil nutrients, evaluated against fossil fuel alternatives. Case studies on operational plants feasibility provide insights technical economic viability at scale. Challenges regarding feedstock logistics, efficiency, commercial scale-up sustainability assessment identified future research focus. In conclusion, finds is promising when integrated appropriate thermochemical, biochemical or digestion technologies. field advancing, further improvements in areas such supply, pretreatment technologies, demonstration will critical realize full potential this emerging bioeconomy sector. recommends steps accelerate commercialization policy frameworks incentivize waste-to-energy solutions.
Language: Английский
Citations
1
Biomolecules, Journal Year: 2024, Volume and Issue: 14(11), P. 1479 - 1479
Published: Nov. 20, 2024
Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-diabetic therapies on cancer progression differing across malignancies. Among these therapies, metformin has gained attention its potential anti-cancer effects, primarily through modulation AMP-activated protein kinase/mammalian target rapamycin (AMPK/mTOR) pathway and induction autophagy. Beyond metformin, other conventional treatments, such as insulin, sulfonylureas (SUs), pioglitazone, dipeptidyl peptidase-4 (DPP-4) inhibitors, have also been examined their roles in biology, though findings are often inconclusive. More recently, novel medications, like glucagon-like peptide-1 (GLP-1) receptor agonists, dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) sodium-glucose co-transporter-2 (SGLT-2) revolutionized DM management by not only improving glycemic control but delivering substantial cardiovascular renal benefits. Given diverse metabolic including anti-obesogenic properties, agents now under meticulous investigation influence tumorigenesis advancement. This review aims to offer comprehensive exploration evolving landscape glucose-lowering treatments implications biology. It critically evaluates experimental evidence surrounding molecular mechanisms which medications may modulate oncogenic signaling pathways reshape tumor microenvironment (TME). Furthermore, it assesses translational research clinical trials gauge practical relevance real-world settings. Finally, explores adjuncts treatment, particularly enhancing efficacy chemotherapy, minimizing toxicity, addressing resistance within framework immunotherapy.
Language: Английский
Citations
0
Reproductive Biology, Journal Year: 2024, Volume and Issue: 25(1), P. 100968 - 100968
Published: Dec. 16, 2024
Language: Английский
Citations
0